Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRSN

Mersana Therapeutics

$11.67

-2.71 (-18.85%)

12:35
09/17/18
09/17
12:35
09/17/18
12:35
Recommendations
Mersana Therapeutics analyst commentary at H.C. Wainwright »

H.C. Wainwright boosts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

MRSN

Mersana Therapeutics

$12.51

-1.87 (-13.00%)

11:03
09/17/18
09/17
11:03
09/17/18
11:03
Recommendations
Mersana Therapeutics analyst commentary at JPMorgan »

Mersana partial hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

MRSN

Mersana Therapeutics

$14.38

0.06 (0.42%)

07:32
09/17/18
09/17
07:32
09/17/18
07:32
Hot Stocks
Breaking Hot Stocks news story on Mersana Therapeutics »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

MRSN

Mersana Therapeutics

$14.38

0.06 (0.42%)

07:12
09/17/18
09/17
07:12
09/17/18
07:12
Hot Stocks
Mersana Therapeutics announces FDA lifts partial clinical hold on XMT-1522 »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

MRSN

Mersana Therapeutics

$14.38

0.06 (0.42%)

06:55
09/17/18
09/17
06:55
09/17/18
06:55
Hot Stocks
Breaking Hot Stocks news story on Mersana Therapeutics »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Over a month ago
KPTI

Karyopharm

$18.50

0.47 (2.61%)

, VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.50

0.47 (2.61%)

VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

VRNA

Verona Pharma

$13.10

-0.3 (-2.24%)

AVRO

AvroBio

$40.52

-0.08 (-0.20%)

ASND

Ascendis Pharma

$67.70

-0.8 (-1.17%)

OBSV

ObsEva

$12.98

-1.02 (-7.29%)

OMER

Omeros

$20.63

1.45 (7.56%)

NVCR

Novocure

$36.85

-0.1 (-0.27%)

XNCR

Xencor

$40.97

0.28 (0.69%)

PRTK

Paratek Pharmaceuticals

$10.10

0.45 (4.66%)

MGTA

Magenta Therapeutics

$12.99

0.09 (0.70%)

CRVS

Corvus Pharmaceuticals

$9.03

-0.4 (-4.24%)

AKAO

Achaogen

$5.66

-0.165 (-2.84%)

ALBO

Albireo Pharma

$31.77

0.17 (0.54%)

EIGR

Eiger BioPharmaceuticals

$10.05

0.375 (3.88%)

STML

Stemline

$15.40

0.25 (1.65%)

SRRA

Sierra Oncology

$1.95

-0.11 (-5.34%)

ABUS

Arbutus Biopharma

$9.20

-0.45 (-4.66%)

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

SRRK

Scholar Rock

$14.00

0.71 (5.34%)

ARGX

Argenx

$87.50

0.19 (0.22%)

ALNA

Allena Pharmaceuticals

$10.98

0.11 (1.01%)

KURA

Kura Oncology

$19.75

-0.2 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

16:26
08/14/18
08/14
16:26
08/14/18
16:26
Earnings
Mersana Therapeutics reports Q2 EPS (54c), consensus (58c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 04

    Sep

KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

, VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

09:08
08/14/18
08/14
09:08
08/14/18
09:08
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

VRNA

Verona Pharma

$13.40

-0.47 (-3.39%)

AVRO

AvroBio

$40.60

0.61 (1.53%)

ASND

Ascendis Pharma

$68.50

0.82 (1.21%)

OBSV

ObsEva

$14.00

-0.96 (-6.42%)

OMER

Omeros

$19.18

1.41 (7.93%)

NVCR

Novocure

$36.95

1 (2.78%)

XNCR

Xencor

$40.69

0.38 (0.94%)

PRTK

Paratek Pharmaceuticals

$9.65

-0.4 (-3.98%)

MGTA

Magenta Therapeutics

$12.90

-0.16 (-1.23%)

CRVS

Corvus Pharmaceuticals

$9.43

0.12 (1.29%)

AKAO

Achaogen

$5.82

-0.35 (-5.67%)

ALBO

Albireo Pharma

$31.60

0.42 (1.35%)

EIGR

Eiger BioPharmaceuticals

$9.68

0.025 (0.26%)

STML

Stemline

$15.15

0.15 (1.00%)

SRRA

Sierra Oncology

$2.06

(0.00%)

ABUS

Arbutus Biopharma

$9.65

0.15 (1.58%)

MRSN

Mersana Therapeutics

$12.71

-0.205 (-1.59%)

SRRK

Scholar Rock

$13.29

-1.11 (-7.71%)

ARGX

Argenx

$87.31

-2.79 (-3.10%)

ALNA

Allena Pharmaceuticals

$10.87

0.13 (1.21%)

KURA

Kura Oncology

$19.95

0.95 (5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

07:27
07/20/18
07/20
07:27
07/20/18
07:27
Recommendations
Mersana Therapeutics analyst commentary at H.C. Wainwright »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

20:45
07/19/18
07/19
20:45
07/19/18
20:45
Downgrade
Mersana Therapeutics rating change at Leerink »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.